Ranibizumab for treatment of type 1 ROP: 5 year outcomes of the RAINBOW Trial

Category Primary study
JournalInvestigative ophthalmology & visual science
Year 2023
This article has no abstract
Epistemonikos ID: 20cc0580103c6b59008043d70a42134aa5731372
First added on: Dec 07, 2023